newsfilter
← Latest News
GlobeNewswire·

Lumos Pharma to Report Full Year 2022 Financial Results and Host Conference Call on March 1, 2023

AUSTIN, Texas, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2